1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legislation

Companies Support Telehealth Reforms – But Seek Demo Projects First

Responding to a chronic care reform effort by the Senate Finance Committee, AdvaMed, device firms and several medical groups asked for demo projects and waivers to appropriately expand the use of telehealth services.

Device firms are pleased that the Senate Finance Committee is exploring options to increase access to telehealth services for patients with chronic conditions, but they want to ensure that reimbursement models are tested on a small scale before wider roll out, AdvaMed and other industry groups told the committee.

The Finance Committee released its “Bipartisan Chronic Care Working Group Policy Options” document

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

US FDA Appropriations Cut In Proposed Shutdown-Ending Agreement

 
• By Derrick Gingery

But the Senate’s reduction would not be as much as the House of Representatives and President Trump proposed earlier this year, which is likely a win for the agency.

Makary And Oz Tout Successes At Their Respective Agencies, Say They Are Breaking Down Walls

 
• By Brian Bossetta

Nearly one year into leading their agencies, US FDA Commission Marty Makary and CMS Administrator Mehmet Oz took to the stage together at the Milken Institute’s Future of Health Summit 2025 to highlight what they see as progress and lay out plans for the road ahead.

A Trillion On The Table. Addressing Disparities In Women’s Health Isn’t Just Right. It’s Smart.

 
• By Brian Bossetta

Advocates spanning the spectrum of women’s health met in Manhattan to discuss the gender disparities that remain in healthcare and how public policy can correct them and the enormous ROI investors in women’s health can potentially reap.

Stakeholders Advocate for FDA Modernization In Senate Biotech Hearing

 
• By Elizabeth Orr

During a Senate hearing on Oct. 29, stakeholders advocated for FDA reforms to boost U.S. biotech innovation amid growing competition, particularly from China. Key recommendations included enhancing AI use, improving clinical trial processes, and streamlining regulatory practices.

More from Policy & Regulation

Can Chatbots Treat Depression? FDA Advisers Urge Caution on Generative AI Tools

 
• By Elizabeth Orr

FDA advisers gave a cautious nod to the idea of using generative AI in mental healthcare during a Nov. 6 panel meeting, saying evidence-backed tools could help expand access – but warning that safety, oversight, and the irreplaceable human connection remain major unanswered questions.

Makary And Oz Tout Successes At Their Respective Agencies, Say They Are Breaking Down Walls

 
• By Brian Bossetta

Nearly one year into leading their agencies, US FDA Commission Marty Makary and CMS Administrator Mehmet Oz took to the stage together at the Milken Institute’s Future of Health Summit 2025 to highlight what they see as progress and lay out plans for the road ahead.

Global Medtech Guidance Tracker: October 2025

 
• By Vibha Sharma

Stay current on regulatory guidelines from around the world with Medtech Insight’s Guidance Tracker. Over 60 documents have been posted on the tracker since its last update.